Tales of tails: Regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging

Immunological Reviews

Volumn 160, Issue , 1997, Pages 43-54

  Weng, Nan Ping ^a,d   Palmer, Larry D ^a   Levine, Bruce L ^b   Lane, H Clifford ^c   June, Carl H ^b   Hodes, Richard J ^a,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; TELOMERASE;

AGING; B LYMPHOCYTE; CELL DIVISION; ENZYME ACTIVITY; ENZYME REGULATION; GERMINAL CENTER; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MEMORY CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TELOMERE; TONSIL;

ANIMALS; CELL AGING; CELL DIFFERENTIATION; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; TELOMERASE; TELOMERE;

EID: 0031463644     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb01026.x     Document Type: Review

References (88)

1. Von Boehmer H. T cell development and selection in the thymus. Bone Marrow Transplant 1992;9(Suppl 1): 46-48.
2. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996;381:751-758.
3. Zinkernagel RM, Bachmann MF, Kundig TM, Oehen S, Pirchet H, Hengartner H. On immunological memory. Annu Rev Immunol 1996;14:333-367.
4. Zhang J, MacLennan IC, Liu YJ, Lane P. Is rapid proliferation in B centroblasts linked to somatic mutation in memory B cell clones? Immunol Lett 1988;18:297-300.
5. Vitetta ES, Berton MT, Burger C, Kepron M, Lee WT, Yin X. Memory B and T cells. Annu Rev Immunol 1991;9:193-217.
6. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-573.
7. Zakian VA. Telomeres: beginning to understand the end. Science 1995;270:1601-1607.
8. Allshire RC, Dempster M, Hastie ND. Human telomeres contain at least three types of G-rich repeats distributed non-randomly. Nucleic Acids Res 1989;17:4611-4627.
9. de Lange T, et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990;10:518-527.
10. Allsopp RC, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992;89:10114-10118.
11. Fang G, Cech TR. Telomere proteins. In: Blackburn EH, Greider CW, eds. Telomeres. New York: Cold Spring Harbor Laboratory Press; 1995. p. 69-105.
12. Chong L, et al. A human telomeric protein. Science 1995;270:1663-1667.
13. Smith S, de Lange T. TRF1, a mammalian telomeric protein. Trends Genet 1997;13:21-26.
14. Luderus MEE, van Steensel B, Chong L, Sibon OCM, Cremers FFM, de Lange T. Structure, subnuclear distribution, and nuclear matrix association of the mammalian telomeric complex. J Cell Biol 1996;135:867-881.
15. Kirk KE, Harmon BP, Reichardt IK, Sedat JW, Blackburn EH. Block in anaphase chromosome separation caused by a telomerase template mutation. Science 1997;275:1478-1481.
16. Sandell LL, Zakian VA. Loss of a yeast telomere: arrest, recovery, and chromosome loss. Cell 1993;75:729-739.
17. Greider CW, Harley CB. Telomeres and telomerase in cell senescence and immortalization. In: Holbrook NJ, Martin GR, Lockshin RA, eds. Cellular aging and cell death. New York: Wiley-Liss, Inc; 1996. p. 123-138.
18. Watson J. Origin of concatemeric T7 DNA. Nat New Biol 1972;239:197-201.
19. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973;41:181-190.
20. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-460.
21. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994;91:9857-9860.
22. Slagboom PE, Droog S, Boomsma DI. Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 1994;55:876-882.
23. Lindsey J, McGill NI, Lindsey LA, Green DK, Cooke HJ. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991;256:45-48.
24. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:866-868.
25. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 1995;92: 11190-11194.
26. Vaziri H, et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993;52:661-667.
27. Schulz VP, et al. Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner syndrome cells. Hum Genet 1996;97:750-754.
28. Cooke HJ, Smith BA. Variability at the telomeres of the human X/Y pseudoautosomal region. Cold Spring Harb Symp Quant Biol 1986;51 (Pt 1):213-219.
29. Blackburn EH. Telomerases. Annu Rev Biochem 1992;61:113-129.
30. Feng J, et al. The RNA component of human telomerase. Science 1995;269:1236-1241.
31. Harrington L, et al. A mammalian telomerase-associated protein. Science 1997;275:973-977.
32. Nakamura TM, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997;277:955-959.
33. 31b. Meyerson M, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997;90:785-795.
34. Kim NW, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
35. de Lange T. Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 1994;91:2882-2885.
36. Shay JW, Gazdar AF. Origins of telomerase in the early detection of cancer. J Clin Pathol 1997;50:106-109.
37. Murnane JP, Sabatier L, Marder BA, Morgan WF. Telomere dynamics in an immortal human cell line. EMBO J 1994;13:4953-4962.
38. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995;14:4240-4248.
39. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995;92:9082-9086.
40. Hiyama K, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711-3715.
41. Weng N, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996;183:2471-2479.
42. Norrback KF, Dahlenborg K, Carlsson R, Roos G. Telomerase activation in normal B-lymphocytes and non-Hodgkins lymphomas. Blood 1996;88:222-229.
43. Igarashi H, Sakaguchi N. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem Biophys Res Commun 1996;219:649-655.
44. Buchkovich KJ, Greider CW Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell 1996;7:1443-1454.
45. Bodnar AG, Kim NW, Effros R, Chiu CP. Mechanism of telomerase induction during T cell activation. Exp Cell Res 1996;228:58-64.
46. Weng N, Levine BL, June CH, Hodes RJ. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci USA 1995;92: 11091-11094.
47. Batliwalla F, Monteiro J, Serrano D, Gregersen PK. Oligoclonality of CD8+ T cells in health and disease: aging, infection, or immune regulation? Hum Immunol 1996;48:68-76.
48. Lloyd TE, Yang L, Tang DN, Bennett T, Schober W, Lewis D. Regulation of CD28 costimulation in human CD8+ T cells. J Immunol 1997;158:1551-1558.
49. Monteiro J, Batliwalla F, Ostrer H, Gregersen PK. Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J Immunol 1996;156:3587-3590.
50. Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, Fauci AS. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. N Engl J Med 1985;313:79-84.
51. Pantaleo G, Fauci AS. New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 1995;13:487-512.
52. Palmer LD, Weng NP, Levine BL, June CH, Lane HC, Hodes RJ. Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4+ and CD8+ T cells from HIV-discordant monozygotic twins. J Exp Med 1997;185:1381-1386.
53. Wolthers KC, et al. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science 1996;274:1543-1547.
54. Levine BL, Ueda Y, Craighead N, Huang ML, June CH. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro. Int Immunol 1995;7:891-904.
55. Morrison SJ, Prowse KR, Ho P, Weissman IL. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 1996;5:207-216.
56. Chiu CP, et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996;14:239-248.
57. Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MA. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 1997;90:182-193.
58. Hohaus S, et al. Telomerase activity in human hematopoietic progenitor cells. Haematologica 1997;82:262-268.
59. Weng N, Levine BL, June CH, Hodes RJ. Regulation of telomerase RNA template expression in human T lymphocyte development and activation. J Immunol 1997;158:3215-3220.
60. Wange RL, Samelson LE. Complex complexes: signaling at the TCR. Immunity 1996;5:197-205.
61. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996;56:645-650.
62. Pan C, Xue B, Ellis TM, Peace DJ, Diaz MO. Changes in telomerase activity and telomere length during human T lymphocyte senescence. Exp Cell Res 1997;231:346-353.
63. Liu YJ, Arpin C. Germinal center development. Immunol Res 1997;156:111-126.
64. Tarlinton DM. Germinal centers: a second childhood for lymphocytes. Curr Biol 1997;7: R155-R159.
65. Neuberger MS, Milstein C. Somatic hypermutation. Curr Opin Immunol 1995;7:248-254.
66. Kelsoe G. The germinal center: a crucible for lymphocyte selection. Semin Immunol 1996;8:179-184.
67. Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med 1994;180:329-339.
68. Kepler TB, Perelson AS. Cyclic re-entry of germinal center B cells and the efficiency of affinity maturation. Immunol Today 1993;14:412-415.
69. Coffman RL, Lebman DA, Rothman P. The mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 1996;54:229-270.
70. Weng NP, Granger L, Hodes RJ. Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci USA 1997;94: 10827-10832.
71. Guerrini AM, Camponeschi B, Ascenzioni F, Piccolella E, Donini P. Subtelomeric as well as telomeric sequences are lost from chromosomes in proliferating B lymphocytes. Hum Mol Genet 1993;2:455-460.
72. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994;68:3410-3414.
73. Hu BT, Lee SC, Marin E, Ryan DH, Insel RA. Telomerase is up-regulated in human germinal center B cells in vivo and can be re-expressed in memory B cells activated in vitro. J Immunol 1997;159:1068-1071.
74. Billian G, Bella C, Mondiere P, Defrance T. Identification of a tonsil IgD+ B cell subset with phenotypical and functional characteristics of germinal center B cells. Eur J Immunol 1996;26:1712-1719.
75. Holt SE, Wright WE, Shay JW. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 1996;16:2932-2939.
76. Savoysky E, et al. Down-regulation of telomerase activity is an early event in the differentiation of HL60 cells. Biochem Biophys Res Commun 1996;226:329-334.
77. Bestilny LJ, Brown CB, Miura Y, Robertson LD, Riabowol KT. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res 1996;56:3796-3802.
78. Kelsoe G. Life and death in germinal centers (redux). Immunity 1996;4:107-111.
79. Tarlinton DM, Smith KG. Apoptosis and the B cell response to antigen. Int Rev Immunol 1997;15:53-71.
80. Igarashi H, Sakaguchi N. Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood 1997;89:1299-1307.
81. Brunetti M, Martelli N, Colasante A, Piantelli M, Musiani P, Aiello FB. Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. Blood 1995;86:4199-4205.
82. Boise LB, Minn AJ, June CH, Lindsten T, Thompson CB. Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc Natl Acad Sci USA 1995;92:5491-5495.
83. Mandal M, Kumar R. Bcl-2 modulates telomerase activity. J Biol Chem 1997;272:14183-14187.
84. Yashima K, et al. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 1997;50:110-117.
85. Autexier C, Greider CW. Telomerase and cancer: revisiting the telomere hypothesis. Trends Biochem Sci 1996;21:387-391.
86. Ohyashiki K, Ohyashiki JH. Telomere dynamics and cytogenetic changes in human hematologic neoplasias: a working hypothesis. Cancer Genet Cytogenet 1997;94:67-72.
87. Lansdorp PM, et al. Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 1996;5:685-691.
88. Ohyashiki K, et al. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res 1997;57:2100-2103.